SEMAXANIB
UNII 71IA9S35AJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Semaxanib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 71IA9S35AJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 194413-58-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

71IA9S35AJ

CAS Registry Number

194413-58-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SEMAXANIB

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C15H14N2O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WUWDLXZGHZSWQZ-WQLSENKSSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C1831

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

5329098

Unique identification number in the NCBI database of chemical substances.

INN ID

8004

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KK-118

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C/1(\C(Nc2c1cccc2)=O)=C\c3[nH]c(C)cc3C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Semaxanib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.